H1-antihistamine-refractory chronic spontaneous urticaria: it's worse than we thought - first results of the multicenter real-life AWARE study.
M MaurerP StaubachU RaapG Richter-HuhnA BauerFranziska RuёffT JakobA S YazdiV MahlerN WagnerU LippertU HillenA SchwinnM PawlakN BehnkeK ChaoucheN Chapman-RothePublished in: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology (2017)
This study reveals that German H1-antihistamine-refractory CSU patients have high rates of uncontrolled disease, angioedema, and comorbid CIndU, are undertreated, have impaired QoL, and rely heavily on healthcare resources.